Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?

被引:88
作者
Davenport, Andrew [1 ]
Sheikh, Mohammed Faisal [2 ]
Lamb, Edmund [3 ]
Agarwal, Banwari [4 ]
Jalan, Rajiv [2 ]
机构
[1] Royal Free Hosp, UCL Med Sch, Div Med, UCL Ctr Nephrol, London, England
[2] Royal Free Hosp, Liver Failure Grp, UCL Med Sch, Div Med,UCL Inst Liver & Digest Hlth, London, England
[3] East Kent Hosp Univ NHS Fdn Trust, Clin Biochem, Canterbury, Kent, England
[4] Royal Free Hosp, Intens Care Unit, London, England
关键词
ACLF; acute kidney injury; cirrhosis; hepatorenal syndrome; SPONTANEOUS BACTERIAL PERITONITIS; GELATINASE-ASSOCIATED LIPOCALIN; TERLIPRESSIN PLUS ALBUMIN; RENAL BLOOD-FLOW; INTENSIVE-CARE-UNIT; CIRRHOTIC-PATIENTS; CREATININE MEASUREMENT; SERUM CREATININE; SYNDROME TYPE-1; DECOMPENSATED CIRRHOSIS;
D O I
10.1016/j.kint.2017.04.048
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal dysfunction occurs in 25% to 50% of patients with cirrhosis admitted to the hospital with an acute episode of hepatic decompensation and may be due to underlying chronic kidney disease, an acute deterioration, or both. An acute deterioration in renal function in cirrhotic patients is now collectively referred to as acute kidney injury (AKI), which has been subclassified into different grades of severity that identify prognostic groups. Acute-on-chronic liver failure is characterized by acute hepatic and/or extrahepatic organ failure driven by a dysregulated immune response and systemic inflammatory response. AKI is also one of the defining features of ACLF and a major component in grading the severity of acute-on-chronic liver failure. As such, the pattern of AKI now observed in patients admitted to the hospital with acutely decompensated liver disease is likely to be one of inflammatory kidney injury including acute tubular injury (referred in this review as non-hepatorenal syndrome [HRS]-AKI) rather than HRS. As the management and supportive treatment of non-HRS-AKI potentially differ from those of HRS, then from the nephrology perspective, it is important to distinguish between non-HRS-AKI and HRS-AKI when reviewing patients with acute-on-chronic liver failure and AKI, so that appropriate and early management can be instituted.
引用
收藏
页码:1058 / 1070
页数:13
相关论文
共 138 条
[31]   AKI in a Patient with Cirrhosis and Ascites [J].
Davenport, Andrew .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (12) :2041-2048
[32]   Medical management of hepatorenal syndrome [J].
Davenport, Andrew ;
Ahmad, Jawad ;
Al-Khafaji, Ali ;
Kellum, John A. ;
Genyk, Yuri S. ;
Nadim, Mitra K. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (01) :34-+
[33]   Pitfalls in assessing renal function in patients with cirrhosis-potential inequity for access to treatment of hepatorenal failure and liver transplantation [J].
Davenport, Andrew ;
Cholongitas, Evangelos ;
Xirouchakis, Elias ;
Burroughs, Andrew Kenneth .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (09) :2735-2742
[34]  
de Carvalho GC, 2012, ANN HEPATOL, V11, P90
[35]   Acute Kidney Injury Network Criteria as a Predictor of Hospital Mortality in Cirrhotic Patients With Ascites [J].
de Carvalho, Juliana Ribeiro ;
Villela-Nogueira, Cristiane Alves ;
Luiz, Ronir Raggio ;
Guzzo, Paula Lustosa ;
da Silva Rosa, Juliana Maria ;
Rocha, Eduardo ;
Moraes Coelho, Henrique Sergio ;
Perez, Renata de Mello .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2012, 46 (03) :E21-E26
[36]   Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation [J].
de Mattos, Angelo Z. ;
de Mattos, Angelo A. ;
Ribeiro, Rodrigo A. .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 28 (03) :345-351
[37]   Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis [J].
Dong, Tien ;
Aronsohn, Andrew ;
Reddy, K. Gautham ;
Te, Helen S. .
DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (12) :3621-3626
[38]   Management of Acute-on-Chronic Liver Failure [J].
Durand, Francois ;
Nadim, Mitra K. .
SEMINARS IN LIVER DISEASE, 2016, 36 (02) :141-152
[39]   Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome:: A pilot study [J].
Duvoux, C ;
Zanditenas, D ;
Hézode, C ;
Chauvat, A ;
Monin, JL ;
Roudot-Thoraval, F ;
Mallat, A ;
Dhumeaux, D .
HEPATOLOGY, 2002, 36 (02) :374-380
[40]   RENAL FAILURE IN PATIENT WITH CIRRHOSIS - ROLE OF ACTIVE VASOCONSTRICTION [J].
EPSTEIN, M ;
BERK, DP ;
HOLLENBERG, NK ;
ADAMS, DF ;
CHALMERS, TC ;
ABRAMS, HL ;
MERRILL, JP .
AMERICAN JOURNAL OF MEDICINE, 1970, 49 (02) :175-+